Coherus Biosciences | CHRS - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 364.22B 20.46B 2026-05
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 5.66B 217M 2026-05
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Baxter International USD 8.67B 1.15B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Fujifilm JPY 3.95T 264.17B 2026-05
Gilead Sciences USD 167.39B 5.6B 2026-05
Merck USD 297.1B 35.84B 2026-03
Myriad Genetics USD 575M 98M 2025-12
Pacira USD 915M 149M 2026-03
Perrigo USD 1.58B 265M 2026-05
Pfizer USD 147.4B 6.42B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sarepta Therapeutics USD 2.16B 123M 2026-05
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05
Xencor USD 795M 98M 2026-05
Zoetis USD 39.98B 9.73B 2026-05